Search clinical trials for: Fedratinib Pill

Total 2770 results

H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Recruiting

Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)

MDS | Myeloproliferative Neoplasm | Chronic Neutrophilic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Recruiting

Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms

Myeloproliferative Neoplasm

United States
Bristol-Myers Squibb

Recruiting

A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

Korea, Republic of
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Real World Evidence of Fedratinib Effectiveness in MF (REALFed)

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

Italy
Celgene
Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation

Completed

A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM)

Primary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Canada
Celgene
Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation

Completed

A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment

Healthy Volunteers | Hepatic Impairment

United States
Celgene

Active, not recruiting

A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

Primary Myelofibrosis

Japan
Bristol-Myers Squibb

Completed

A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants

Healthy Volunteers

United States
Celgene
Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation

Available

Individual Patient Compassionate Use of Fedratinib

Myelofibrosis

United States
Celgene
Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation

Active, not recruiting

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM2)

Primary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera

Australia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom
Guang'anmen Hospital of China Academy of Chinese...
Tasly Pharmaceuticals, Inc.

Completed

Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes

Diabetes Mellitus, Type 2

China
Bristol-Myers Squibb

Active, not recruiting

A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

Myelofibrosis

Italy, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
Instituto Nacional de Perinatologia Isidro Espinosa...

Completed

Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio (EDIMI216OHE1)

Breast Cancer
Puma Biotechnology, Inc.

Completed

Study Evaluating HKI-272 Administered to Healthy Subjects

Healthy

United States
UNC Lineberger Comprehensive Cancer Center

No longer available

Single Subject Neratinib in Bladder Cancer (NRR)

Bladder Cancer

United States
Pierre Fabre Medicament

Not yet recruiting

Treatment Patterns of Neratinib in HER2+ EBC in China

Breast Cancer

China
Puma Biotechnology, Inc.

Completed

Study Evaluating HKI-272 in Tumors

Breast Neoplasms

United States
Puma Biotechnology, Inc.

Completed

A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors

Tumors

Japan
Puma Biotechnology, Inc.

Completed

Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)

Healthy Subjects

United States
Pierre Fabre Pharma GmbH
iOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Active, not recruiting

Real-life Pan-HER-blockade With Neratinib (ELEANOR)

Breast Neoplasm

Austria, Germany, Switzerland
Puma Biotechnology, Inc.

Completed

Study Evaluating The Tolerability Of Multiple Doses Of HKI-272

Healthy Subjects

United States
Fox Chase Cancer Center
National Comprehensive Cancer Network; Puma Biotechnology, Inc.

Recruiting

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Gastric Cancer

United States
University of Alabama at Birmingham

Completed

Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss (GCE)

Obesity | Body Weight | Eating Behavior | Hunger

United States
Puma Biotechnology, Inc.

Completed

A Single Dose Bioequivalence Study Of Neratinib In Healthy Subjects

Healthy

United States
Puma Biotechnology, Inc.

Withdrawn

Study Evaluating The Effect Of A High-Fat Meal On The Pharmacokinetics Of Neratinib

Healthy
Peking Union Medical College Hospital
The Second Hospital of Hebei Medical University; China-Japan Friendship Hospital and other collaborators

Unknown

Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. (AGNH2018)

Acute Ischemic Stroke

China
Joseph Jurcic
Bristol-Myers Squibb

Recruiting

Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

Myeloproliferative Neoplasm

United States
NYU Langone Health

Completed

The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut Microbiota

Cirrhosis

United States
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations (CVL009-2001)

NSCLC

China
Virginia Commonwealth University
GlaxoSmithKline; Puma Biotechnology, Inc.

Recruiting

Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer (iNNOVATE)

Ovarian Cancer | Advanced Solid Tumor

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; Puma Biotechnology, Inc.

Withdrawn

Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate Adenocarcinoma

United States
Capital Medical University

Not yet recruiting

The Efficacy of Combination of Traditional Tibetan and Remote Ischemic Conditioning on High Altitude Polycythemia

High Altitude Polycythemia
Guangzhou University of Traditional Chinese Medicine

Unknown

Clinical Observation on the Treatment of Motor and Sensory Dysfunction After Stroke With Ruyizhenbao Pill

Post-stroke Patients With Motor and Sensory Dysfunction

China
Shanghai Jiao Tong University School of Medicine
Shanghai University of Traditional Chinese Medicine

Recruiting

Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency (RLDP)

Presbycusis | Age-related Hearing Loss | Hearing Disorders and Deafness

China
Hvidovre University Hospital

Not yet recruiting

Avatrombopaq In Patients With Cirrhosis (AIPAC)

Cirrhosis, Liver | Procedural Bleeding | Thrombocytopenia; Drugs
Andreas Josefsson
Göteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaborators

Terminated

Enzalutamide Treatment in COVID-19 (COVIDENZA)

COVID-19 | Corona Virus Infection

Sweden
Massachusetts General Hospital
Ganeden Biotech, Inc.

Terminated

Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder

Irritable Bowel Syndrome | Major Depressive Disorder

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

Small Cell Lung Carcinoma | Small-cell Lung Cancer

United States
Manan Shukla

Completed

Feasibility of Ripple Health Smart Pill Caps in Clinical Settings

Asthma | Chronic Disease

United States
Tasly Pharmaceutical Group Co., Ltd

Not yet recruiting

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Plaque Psoriasis

China
Jules Bordet Institute

Withdrawn

Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer (NeraBrain)

Breast Cancer | Brain Metastases
Dongzhimen Hospital, Beijing

Not yet recruiting

Suhexiang Pill for Acute Ischemic Stroke: A Registry Study (SUNRISE)

Ischemic Stroke

China
Peking University Third Hospital

Recruiting

The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients

Transthyretin Amyloidosis

China
The Orthopedic Foundation

Completed

Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

Cervical Dystonia

United States
China Academy of Chinese Medical Sciences
Wangjing Hospital, China Academy of Chinese Medical Sciences

Unknown

A Registry Study of Shujinjianyao Pill Used in Clinical Real World

Sciatica
Shanghai University of Traditional Chinese Medicine
Changhai Hospital; Shanghai Ninth People's Hospital Affiliated to Shanghai... and other collaborators

Unknown

A Post-marketing Evaluation of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy

Cervical Radiculopathy

China
Harvard University Faculty of Medicine
Beth Israel Deaconess Medical Center

Completed

Harnessing Placebo Effects: Non-Deceptive Use of Placebo in Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke

Post-stroke Cognitive Impairment

China
Loma Linda University

Completed

"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"

Overactive Bladder | Menopause | Caffeine

United States
Tianjin Medical University Cancer Institute and...

Recruiting

A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations

Breast Cancer

China

Search clinical trials for: Fedratinib Pill

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations